SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors digest significant institutional accumulation and strategic partnerships, including a recent major defense contract and collaboration with top-tier technology firms. Community sentiment remains bullish, with many traders focusing on the company's long-term potential as an AI infrastructure leader and anticipating a breakout from its recent trading range.

MATH is a one stop crypto solution platform which contains MathWallet, MATH VPOS Pool, MathDEX, MATH dApp Store, MATH Staking, MATH Pay, MATH Chain, etc.

MATH

The MATH community is actively debating the token's potential for a significant breakout, fueled by its low market cap and historical patterns of sudden, sharp volatility. While some investors are expressing frustration over stagnant price action and questioning leadership, others remain optimistic that upcoming altcoin cycle trends could act as a catalyst for a sustained move upward.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is attracting intense retail attention as traders debate the ETF's structural decay and its role as a high-volatility hedge against Middle East geopolitical instability. The community remains sharply divided between those betting on aggressive upside driven by fear-based volume and those advocating for short positions to capitalize on the instrument's long-term negative roll yield.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing a surge in investor interest driven by recent production order wins for its Sonoma high-power test platforms, which are being integrated into critical hyperscale AI infrastructure. The community is focused on the potential for a massive commercial scale-up in the coming year, with active debates centered on whether recent contract wins represent a definitive pivot toward sustainable, high-volume growth that justifies current valuation levels.

ElizaOS

ELIZAOS is capturing significant trader interest as the community focuses on a major token migration and the potential for a technical rebound following recent volatility. Investors are actively debating key support levels and monitoring for a breakout, driven by the project's expanding role in cross-chain AI agent infrastructure and ongoing exchange-led promotional campaigns.

USDC is a fully collateralized US dollar stablecoin. USDC is the bridge between dollars and trading on cryptocurrency exchanges. The technology behind CENTRE makes it possible to exchange value between people, businesses and financial institutions just like email between mail services and texts between SMS providers. We believe by removing artificial economic borders, we can create a more inclusive global economy.

USD Coin

USD Coin is gaining attention as community members analyze its structural growth, regulatory developments, and expanding utility across major blockchain networks. Sentiment is mixed, with some focusing on long-term institutional adoption and stablecoin integration into decentralized finance, while others express concerns regarding centralization risks and broader regulatory uncertainty.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is attracting heavy investor attention ahead of their upcoming earnings release, with community discussion centered on whether the company can deliver a decisive revenue beat to counter ongoing skepticism. Shareholders are closely watching for potential regulatory catalysts and management's strategy, while a vocal contingent of traders remains divided between those betting on a long-term turnaround and those bracing for further volatility and dilution.

Plasma is the layer 1 blockchain building the stablecoin infrastructure for a new global financial system.   It is purpose-built for global stablecoin payments, offering zero-fee USD₮ transfers and custom gas tokens to help realise the stablecoin promise of permissionless access to financial services for everyone, everywhere.   Plasma’s global payments coverage and inbound suite of products position it as the native chain for stablecoin payments.

Plasma

Plasma ($XPL) is currently facing significant volatility and intense debate, with the community split between investors viewing it as a high-potential stablecoin infrastructure play and those labeling the project a pump-and-dump scheme. Sentiment is heavily influenced by rapid price fluctuations, concerns over token unlocks, and ongoing speculation regarding the project's long-term utility.

USELESS

USELESS is gaining significant community traction as traders track its consolidation phase and potential for a breakout amid broader altcoin rotation. Discussion centers on its high-beta profile and the irony of its branding, with active debates split between bullish accumulation strategies and skeptical views on its meme-driven longevity.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is experiencing intense community focus as traders brace for potential market volatility stemming from escalating tensions in the Middle East and concerns over oil supply disruptions. Investors are actively debating whether recent diplomatic overtures are genuine or merely market-calming maneuvers, leading to significant volume in both hedging and speculative positions around the ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunovant Batoclimab Flops in Phase 3 TED as Roivant Expands Brepocitinib Into LPP

Roivant Sciences and Priovant Therapeutics executives outlined an expansion of the brepocitinib development program into lichen planopilaris (LPP) and discussed newly released Phase 3 results for batoclimab in thyroid eye disease (TED), which failed to meet its primary endpoint.

Brepocitinib expand...

Roivant Sciences Adds Brepocitinib LPP Trial as Batoclimab Misses Phase III TED Endpoint

Roivant Sciences (NASDAQ:ROIV) outlined plans to expand development of its JAK1/TYK2 inhibitor brepocitinib into lichen planopilaris (LPP) and provided an update on a Phase III thyroid eye disease (TED) trial for batoclimab during a conference call hosted by the company.

Brepocitinib expands into l...

250,468 Shares in Roivant Sciences Ltd. $ROIV Acquired by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC acquired a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 250,468 shares of the company's stock, valued at a...

Assenagon Asset Management S.A. Purchases 6,877,348 Shares of Roivant Sciences Ltd. $ROIV

Assenagon Asset Management S.A. grew its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 11,507.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,937,112 shares of the company's s...

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) have earned an average rating of "Moderate Buy" from the eleven ratings firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendat...

Sanford C. Bernstein Begins Coverage on Roivant Sciences (NASDAQ:ROIV)

Sanford C. Bernstein initiated coverage on shares of Roivant Sciences in a research note on Friday. They set an "outperform" rating and a $35.00 target price for the company...

Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 200,000 Shares

Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of the firm's stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $28.24, for a total value of $5,648,000.00. Following the sale, the chief executive officer directly owned...

Roivant Sciences (NASDAQ:ROIV) CEO Sells 200,000 Shares

Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of Roivant Sciences stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $28.24, for a total value of $5,648,000.00. Following the sale, the chief executive...

Melissa Epperly Sells 41,861 Shares of Roivant Sciences (NASDAQ:ROIV) Stock

Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) Director Melissa Epperly sold 41,861 shares of the company's stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $28.68, for a total value of $1,200,573.48. Following the transaction, the...

Roivant Sciences (NASDAQ:ROIV) Director Melissa Epperly Sells 41,861 Shares

Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) Director Melissa Epperly sold 41,861 shares of the company's stock in a transaction on Monday, March 16th. The stock was sold at an average price of $28.68, for a total transaction of $1,200,573.48. Following the completion of the transaction...

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

Roivant Sciences Ltd

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

ROIV
Roivant Sciences Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ROIV News

ROIVRoivant Sciences Ltd